到2025年,印度将麻风病的流行率降至每10 000人中0.57人,接近消除。 India reduced leprosy prevalence to 0.57 per 10,000 by 2025, nearing elimination.

印度自1981年以来将麻风病流行率降低了99%,到2025年达到每10,000人中0.57人,治疗病例从39.19人减少到0.82人。 India has reduced its leprosy prevalence rate by 99% since 1981, reaching 0.57 per 10,000 in 2025, with treatment cases dropping from 39.19 lakh to 0.82 lakh. 1983年启动的全国根除麻风病方案使早期发现、免费的多种药物治疗以及与Ayushman Bharat和RBSK等国家卫生倡议相结合成为可能。 The National Leprosy Eradication Programme, launched in 1983, enabled early detection, free multidrug therapy, and integration with national health initiatives like Ayushman Bharat and RBSK. 2005年,印度实现了全国消灭1万分之一以下的根除地位,截至2025年,31个州和638个县达到了这一门槛。 India achieved national elimination status—below 1 per 10,000—in 2005 and as of 2025, 31 states and 638 districts meet this threshold. 该国的目标是在2030年之前中断传播,与世卫组织的路线图保持一致,依靠持续的政治意愿、资金和公众参与。 The country aims to interrupt transmission by 2030, aligning with WHO’s roadmap, relying on sustained political will, funding, and public engagement.